Intellia Therapeutics (IntelliaTX) is a biotechnology company developing CRISPR-based gene editing therapies for genetic diseases. It focuses on discovering and advancing in vivo gene editing medicines through internal programs and partnerships. The website uses cookies for operation, analytics, and personalization, and includes a careers portal for talent recruitment.
AI named Intellia Therapeutics from January 2026 to September 2026.
Brand page for intelliatx-com